Close Menu

Clostridium difficile

NEW YORK (GenomeWeb Daily News) – The microbiomes of recipients of fecal microbiota transplants undergo changes immediately following the procedure, and they continue to change, albeit at a much slower pace, for at least 16 weeks after treatment, researchers from the University of Maryland School

Researchers last week provided a glimpse of the clinical performance of a trio of extraction-free molecular assays currently being developed by clinical diagnostics firm Quidel.

Genomics tools provider Lucigen has developed an isothermal amplification polymerase ideally suited for use in loop-mediated isothermal amplification-based assays.

IntelligentMDx said today that it has received US Food and Drug Administration clearance for its IMDx C.

NEW YORK (GenomeWeb News) – IntelligentMDx today said that the US Food and Drug Administration has cleared its C. difficile assay for the Abbott m2000 system.

NEW YORK (GenomeWeb News) – Exposure to symptomatic individuals within healthcare settings may account for just a fraction of Clostridium difficile infections, according to a study from the UK appearing online last night in the New England Journal of Medicine.

NEW YORK (GenomeWeb News) – Microbioal genetic analysis firm OpGen today announced it has received Clinical Laboratory Improvement Amendments certification.

A new automated molecular diagnostic assay to detect toxigenic Clostridium difficile directly from stool samples was found to have comparable sensitivity and specificity to both the gold standard of culture-based testing and reference testing with a competing assay, Ceph

PrimeraDx, a Mansfield, Mass.-based molecular diagnostics firm, is on track to submit its highly multiplexed PCR-based testing system and associated assay for Clostridium difficile to the US Food and Drug Administration this quarter, CEO Matt McManus said recently.

NEW YORK (GenomeWeb News) – Becton Dickinson's BD Diagnostics segment today said that its BD Max Cdiff Assay has been cleared by the US Food and Drug Administration for marketing in the US.

Pages

A New Zealand minister says the country's genetic modification laws need to be re-examined to help combat climate change, the New Zealand Herald reports.

A new analysis finds some cancers receive more nonprofit dollars than others.

An Australian mother's conviction in the deaths of her children may be re-examined after finding that two of the children carried a cardiac arrhythmia-linked gene variant.

In Science this week: comparative analysis of sex differences in mammal gene expression, and more.